These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 7630156)
1. Comparison of the stereoselective effects of a thiadiazinone derivative on contractile parameters and protein phosphorylation in the mammalian ventricle. Neumann J; Bokník P; Schmitz W; Scholz H; Zimmermann N J Cardiovasc Pharmacol; 1995 May; 25(5):789-93. PubMed ID: 7630156 [TBL] [Abstract][Full Text] [Related]
2. The novel cardiotonic agent EMD 53 998 is a potent "calcium sensitizer". Beier N; Harting J; Jonas R; Klockow M; Lues I; Haeusler G J Cardiovasc Pharmacol; 1991 Jul; 18(1):17-27. PubMed ID: 1719287 [TBL] [Abstract][Full Text] [Related]
3. EMD 53998 acts as Ca(2+)-sensitizer and phosphodiesterase III-inhibitor in human myocardium. Uhlmann R; Schwinger RH; Lues I; Erdmann E Basic Res Cardiol; 1995; 90(5):365-71. PubMed ID: 8585857 [TBL] [Abstract][Full Text] [Related]
4. The two mechanisms of action of racemic cardiotonic EMD 53998, calcium sensitization and phosphodiesterase inhibition, reside in different enantiomers. Lues I; Beier N; Jonas R; Klockow M; Haeusler G J Cardiovasc Pharmacol; 1993 Jun; 21(6):883-92. PubMed ID: 7687712 [TBL] [Abstract][Full Text] [Related]
6. A novel thiadiazinone derivative fully reverses acidosis-induced depression of force in cardiac muscle by a calcium-sensitizing effect. Lee JA; Shah N; White J; Orchard CH Clin Sci (Lond); 1993 Feb; 84(2):141-4. PubMed ID: 8382578 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms of the contractile effects of flosequinoxan. Zimmermann N; Bodor GS; Boknik P; Gams E; Jones LR; Neumann J; Scholz H Naunyn Schmiedebergs Arch Pharmacol; 1995 Apr; 351(4):385-90. PubMed ID: 7630429 [TBL] [Abstract][Full Text] [Related]
8. Different chronotropic and inotropic effects of EMD 57033 and EMD 53998, Ca2+ sensitizers, on isolated, blood-perfused dog heart preparations. Lakhe M; Furukawa Y; Yonezawa T; Hirose M; Nagashima Y; Miyashita Y; Chiba S Jpn J Pharmacol; 1998 Apr; 76(4):435-9. PubMed ID: 9623723 [TBL] [Abstract][Full Text] [Related]
9. Ca2+ sensitizing effects of EMD 53998 after troponin replacement in skinned fibres from porcine atria and ventricles. Barth Z; Strauss JD; Heyder S; Van Eyk J; Wiesner RJ; Rüegg JC Pflugers Arch; 1995 Jun; 430(2):220-9. PubMed ID: 7675632 [TBL] [Abstract][Full Text] [Related]
10. Characterization of biochemical effects of CGS 21680C, an A2-adenosine receptor agonist, in the mammalian ventricle. Bokník P; Neumann J; Schmitz W; Scholz H; Wenzlaff H J Cardiovasc Pharmacol; 1997 Dec; 30(6):750-8. PubMed ID: 9436814 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of the contractile effects of levosimendan in the mammalian heart. Bokník P; Neumann J; Kaspareit G; Schmitz W; Scholz H; Vahlensieck U; Zimmermann N J Pharmacol Exp Ther; 1997 Jan; 280(1):277-83. PubMed ID: 8996207 [TBL] [Abstract][Full Text] [Related]
12. Interaction of cardiac troponin C with Ca(2+) sensitizer EMD 57033 and cardiac troponin I inhibitory peptide. Li MX; Spyracopoulos L; Beier N; Putkey JA; Sykes BD Biochemistry; 2000 Aug; 39(30):8782-90. PubMed ID: 10913289 [TBL] [Abstract][Full Text] [Related]
13. Effects of levosimendan on myocardial contractility and Ca2+ transients in aequorin-loaded right-ventricular papillary muscles and indo-1-loaded single ventricular cardiomyocytes of the rabbit. Sato S; Talukder MA; Sugawara H; Sawada H; Endoh M J Mol Cell Cardiol; 1998 Jun; 30(6):1115-28. PubMed ID: 9689586 [TBL] [Abstract][Full Text] [Related]
14. Novel diazinone derivatives separate myofilament Ca2+ sensitization and phosphodiesterase III inhibitory effects in guinea pig myocardium. Ventura C; Miller R; Wolf HP; Beier N; Jonas R; Klockow M; Lues I; Hano O; Spurgeon HA; Lakatta EG Circ Res; 1992 Jun; 70(6):1081-90. PubMed ID: 1533576 [TBL] [Abstract][Full Text] [Related]
15. In vivo evidence of positive inotropism of EMD 57033 through calcium sensitization. Haeusler G; Jonas R; Minck KO; Schliep HJ; Schelling P; Weygandt H; Lues I J Cardiovasc Pharmacol; 1997 May; 29(5):647-55. PubMed ID: 9213208 [TBL] [Abstract][Full Text] [Related]
16. EMD 53998 sensitizes the contractile proteins to calcium in intact ferret ventricular muscle. Lee JA; Allen DG Circ Res; 1991 Oct; 69(4):927-36. PubMed ID: 1934345 [TBL] [Abstract][Full Text] [Related]
17. Effects of the Ca2+ sensitizers EMD 57033 and CGP 48506 on myocardial contractility and Ca2+ transients in human ventricular and atrial myocardium. Brixius K; Reicke S; Reuter H; Schwinger RH Z Kardiol; 2002 Apr; 91(4):312-8. PubMed ID: 12063703 [TBL] [Abstract][Full Text] [Related]
18. [The Ca(2+) sensitizers CGP 48506 and EMD 57033, but not the Na(+) channel modulator BDF 9148, prolong relaxation in isolated cardiomyocytes of the guinea pig]. Brixius K; Hoischen S; Zobel C; Lasek K; Schwinger RH Z Kardiol; 2001 Apr; 90(4):286-91. PubMed ID: 11381577 [TBL] [Abstract][Full Text] [Related]
19. Stereoselectivity of actions of the calcium sensitizer [+]-EMD 60263 and its enantiomer [-]-EMD 60264. Ravens U; Flüss OM; Li Q; Himmel HM; Wettwer E; Klockow M; Lues I Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):733-42. PubMed ID: 9205958 [TBL] [Abstract][Full Text] [Related]
20. A new cardiotonic drug reduces the energy cost of active tension in cardiac muscle. Gross T; Lues I; Daut J J Mol Cell Cardiol; 1993 Mar; 25(3):239-44. PubMed ID: 8510167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]